Secukinumab versus ustekinumab: "CLEAR" conclusions are needed
- PMID: 26979378
- DOI: 10.1016/j.jaad.2015.09.078
Secukinumab versus ustekinumab: "CLEAR" conclusions are needed
Comment on
-
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.J Am Acad Dermatol. 2015 Sep;73(3):400-9. doi: 10.1016/j.jaad.2015.05.013. Epub 2015 Jun 17. J Am Acad Dermatol. 2015. PMID: 26092291 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
